NCT04667156View on ClinicalTrials.gov

Study to Investigate Relative Bioavailability of Different Formulations of SHR6390 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 13, 2020

Primary Completion Date

January 29, 2021

Study Completion Date

January 29, 2021

Conditions

Healthy Volunteers

Interventions

DRUG

SHR6390

SHR6390 new formulation 1(T1) , SHR6390 new formulation 2 (T2) and SHR6390 traditional formulatin were given in a single dose over three cycles

Trial Locations (1)

470071

Zhongnan Hospital of Wuhan University, Wuhan

All Listed Sponsors

lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY

NCT04667156 - Study to Investigate Relative Bioavailability of Different Formulations of SHR6390 in Healthy Subjects | Biotech Hunter | Biotech Hunter